|
|
|
| |
|
Indication:
- Micro invasive treatment of prolapsed intervertebral discs in the cervical, thoracic and lumbar spine
- To avoid general anesthesia because of increased anesthesia risk (age, cardiovascular diseases or others diseases, which exclude an invasive operation)
- Patients with an invasive operation in the past
- Patients who refuse an invasive operation of intervertebral disc
- Treatment of patients with intervertebral disc protrusions
Procedure of therapie:
 Under CT-control the injection point in the respective segment is marked concerning the distance from median line and depth.
|
|
| |
|
After careful disinfection, sterile covering and local anesthesia the puncture needle of the catheter is inserted through the interlaminar fenestra to the target location. |
|
| |
|
The correct localization will be checked by the next CT control. There is no need to apply contrast medium because of the contrast medium containing wall of the new developed catheter. After checking the right position the catheter will be inserted and moved to the prolapsed disc. |
|
| |
|
After the CT check of the catheter the puncture needle will be removed and the catheter will be fixed by a special plaster and sterile covered. |
|
| |
|
The Application schema |
|
| Day |
Monday |
Tuesday |
Wednesday |
Thursday |
Friday |
9.00
h |
Performing the catheter
+ 1+ 2 |
1
+ 4 |
1
+ 4 |
1
+ 4 |
1
+ 4 |
13:00
h |
1 + 3 |
1
+ 3 |
1
+ 3 |
1
+ 3 |
1
+ 2 |
Substances:
|
|
1 Naropin bzw. Lidocain 1 %
2 Lipotalon
3 Osmofundin 15 %
4 Hyaluronidase |
|
|
|
|
|
